Official recall notice

FDA DrugClass IINotable

Lidocaine Ointment USP Recall (Oct 2026)

Product: Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05

Recall date
2026-10-14
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Content Uniformity Specifications

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed Content Uniformity Specifications

Affected products

Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027.

Verify with the official notice →
Share:

Related Recalls

2026-10-21 · FDA_DRUG
FDA Recall: No Brand Name: Compounded veterinary medications
No Brand Name
2026-10-14 · FDA_DRUG
FDA Recall: Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/10, injectable, Packaged in single-use dosage syringes, total mL
Carolina Infusion, LLC
2026-10-14 · FDA_DRUG
FDA Recall: TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL d
Carolina Infusion, LLC
2026-10-14 · FDA_DRUG
FDA Recall: Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HE
K.C. Pharmaceuticals, Inc.